Susquehanna International Group’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $721K | Buy |
|
|||||
|
2024
Q3 | $39.3K | Sell |
|
|||||
|
2024
Q2 | $47.9K | Buy |
|
|||||
|
2024
Q1 | $56.3K | Buy |
|
|||||
|
2023
Q4 | $33.9K | Sell |
|
|||||
|
2023
Q3 | $482K | Buy |
|
|||||
|
2023
Q2 | $731K | Buy |
|
|||||
|
2023
Q1 | $266K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $630K | Sell |
|
|||||
|
2022
Q2 | $680K | Buy |
|
|||||
|
2022
Q1 | $711K | Sell |
|
|||||
|
2021
Q4 | $3.46M | Buy |
|
|||||
|
2021
Q3 | $3.39M | Buy |
|
|||||
|
2021
Q2 | $1.82M | Buy |
|
|||||
|
2021
Q1 | $717K | Sell |
|
|||||
|
2020
Q4 | $742K | Sell |
|
|||||
|
2020
Q3 | $893K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.07M | Sell |
|
|||||
|
2019
Q4 | $2M | Buy |
|
|||||
|
2019
Q3 | $992K | Sell |
|
|||||
|
2019
Q2 | $8.08M | Buy |
|
|||||
|
2019
Q1 | $4.33M | Sell |
|
|||||
|
2018
Q4 | $3.41M | Sell |
|
|||||
|
2018
Q3 | $9.64M | Buy |
|
|||||
|
2018
Q2 | $3.4M | Sell |
|
|||||
|
2018
Q1 | $3.6M | Sell |
|
|||||
|
2017
Q4 | $3.95M | Buy |
|
|||||
|
2017
Q3 | $1.8M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $18.4M | Buy |
|
|||||
|
2016
Q4 | $976K | Sell |
|
|||||
|
2016
Q3 | $932K | Buy |
|
|||||
|
2016
Q2 | $107K | Buy |
|
|||||
|
2016
Q1 | $74K | Sell |
|
|||||
|
2015
Q4 | $395K | Buy |
|
|||||
|
2015
Q3 | $229K | Sell |
|
|||||
|
2015
Q2 | $567K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $114K | Buy |
|